share_log

Matinas BioPharma | 10-K/A: Annual report (Amendment)

SEC ·  Mar 12, 2022 04:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more